This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 20 and 40
years old
The phase for this study is not defined.
Show me locations

The purpose

Preoxygenation optimizes oxygen content in the functional residual capacity (FRC). Adequate preoxygenation is defined by an expiratory oxygen fraction (FEO2) > 90%. Inspiratory support and positive end expiratory pressure (PEEP) can create a better reservoir, improve gas exchange and shorten the time needed for adequate preoxygenation. The goal of the study is to evaluate the efficacy and tolerability of different levels of inspiratory support and positive end expiratory pressure during preoxygenation in healthy subjects.

Provided treatments

  • Other: VS
  • Other: AI-4/PEEP-4
  • Other: AI-6/PEEP-4
Tris trial is registered with FDA with number: NCT00922753. The sponsor of the trial is Maisonneuve-Rosemont Hospital and it is looking for 20 volunteers for the current phase.
Official trial title:
The Efficacy and Tolerability of Different Levels of Inspiratory Support and PEEP During Preoxygenation. A Randomized Controlled Trial.